Great challenges in molecular medicine: Toward personalized medicine

Frontiers in Cell and Developmental Biology

Volumn 1, Issue OCT, 2013, Pages

  Katoh, Masaru ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

Big data; Bio bank; Clinical sequencing; Database; FGF; Hedgehog; Knowledgebase; WNT

Indexed keywords

EID: 84929578648     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2013.00001     Document Type: Article

References (47)

1. Arzumanyan, A., Sambandam, V., Clayton, M. M., Choi, S. S., Xie, G., Diehl, A. M., et al. (2012). Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res. 72, 5912-5920. doi: 10.1158/0008-5472.CAN-12-2329
2. Baylin, S. B., and Jones, P. A. (2011). A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 11, 726-734. doi: 10.1038/nrc3130
3. Beenken, A., and Mohammadi, M. (2009). The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253. doi: 10.1038/nrd2792
4. Brock, H. W., and Fisher, C. L. (2005). Maintenance of gene expression patterns. Dev. Dyn. 232, 633-655. doi: 10.1002/dvdy.20298
5. Buettner, R., Wolf, J., and Thomas, R. K. (2013). Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment. J. Clin. Oncol. 31, 1858-1865. doi: 10.1200/JCO.2012.45.9867
6. Carlsson, P., and Mahlapuu, M. (2002). Forkhead transcription factors: key players in development and metabolism. Dev. Biol. 250, 1-23. doi: 10.1006/dbio.2002.0780
7. Chien, A. J., Conrad, W. H., and Moon, R. T. (2009). A Wnt survival guide: from flies to human disease. J. Invest. Dermatol. 129, 1614-1627. doi: 10.1038/jid.2008.445
8. Ciardiello, F., and Tortora, G. (2008). EGFR antagonists in cancer treatment. N. Engl. J. Med. 358, 1160-1174. doi: 10.1056/NEJMra0707704
9. Clevers, H. (2006). Wnt/β-catenin signaling in development and disease. Cell 127, 469-480. doi: 10.1016/j.cell.2006.10.018
10. Dickson, C., Smith, R., Brookes, S., and Peters, G. (1984). Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37, 529-536. doi: 10.1016/0092-8674(84)90383-0
11. Ellis, L. M., and Hicklin, D. J. (2008). VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8, 579-591. doi: 10.1038/nrc2403
12. Eswarakumar, V. P., Lax, I., and Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149. doi: 10.1016/j.cytogfr.2005.01.001
13. Fisher, C. L., Berger, J., Randazzo, F., and Brock, H. W. (2003). A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11. Gene 306, 115-126. doi: 10.1016/S0378-1119(03)00430-X
14. Gelsi-Boyer, V., Brecqueville, M., Devillier, R., Murati, A., Mozziconacci, M. J., and Birnbaum, D. (2012). Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J. Hematol. Oncol. 5, 12. doi: 10.1186/1756-8722-5-12
15. Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., et al. (2012). Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc. Natl. Acad. Sci. U.S.A. 109, 11717-11722. doi: 10.1073/pnas.1120068109
16. Hannenhalli, S., and Kaestner, K. H. (2009). The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 10, 233-240. doi: 10.1038/nrg2523
17. Jürgens, G. (1985). A group of genes controlling the spatial expression of the bithorax complex in Drosophila. Nature 316, 153-155. doi: 10.1038/316153a0
18. Katoh, M. (2002a). Paradigm shift in gene-finding method: from bench-top approach to desk-top approach. Int. J. Mol. Med. 10, 677-682
19. Katoh, M. (2002b). WNT and FGF gene clusters. Int. J. Oncol. 21, 1269-1273
20. Katoh, M. (2013a). Functional and cancer genomics of ASXL family members. Br. J. Cancer 109, 299-306. doi: 10.1038/bjc.2013.281
21. Katoh, M. (2013b). Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks. Int. J. Mol. Med. 32, 763-767. doi: 10.3892/ijmm.2013.1444
22. Katoh, M., Igarashi, M., Fukuda, H., Nakagama, H., and Katoh, M. (2013). Cancer genetics and genomics of human FOX family genes. Cancer Lett. 328, 198-206. doi: 10.1016/j.canlet.2012.09.017
23. Katoh, M., and Katoh, M. (2003). Identification and characterization of ASXL2 gene in silico. Int. J. Oncol. 23, 845-850
24. Katoh, M., and Katoh, M. (2004a). Human FOX gene family. Int. J. Oncol. 25, 1495-500
25. Katoh, M., and Katoh, M. (2004b). Identification and characterization of ASXL3 gene in silico. Int. J. Oncol. 24, 1617-1622
26. Katoh, M., and Katoh, M. (2004c). Identification and characterization of human FOXN5 and rat Foxn5 genes in silico. Int. J. Oncol. 24, 1339-1344
27. Katoh, M., and Katoh, M. (2007). WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 13, 4042-4045. doi: 10.1158/1078-0432.CCR-06-2316
28. Katoh, Y., and Katoh, M. (2009). Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr. Mol. Med. 9, 873-886. doi: 10.2174/156652409789105570
29. Katoh, M., and Nakagama, H. (2013). FGF receptors: cancer biology and therapeutics. Med. Res. Rev. doi: 10.1002/med.21288. [Epub ahead of print]
30. Koike, J., Takagi, A., Miwa, T., Hirai, M., Terada, M., and Katoh, M. (1999). Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochem. Biophys. Res. Commun. 262, 39-43. doi: 10.1006/bbrc.1999.1161
31. Kwak, E. L., Bang, Y. J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., et al. (2010). Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363, 1693-1703. doi: 10.1056/NEJMoa1006448
32. Lagerström, M. C., and Schiöth, H. B. (2008). Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339-357. doi: 10.1038/nrd2518
33. Lappano, R., and Maggiolini, M. (2011). G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 10, 47-60. doi: 10.1038/nrd3320
34. Lehmann, O. J., Sowden, J. C., Carlsson, P., Jordan, T., and Bhattacharya, S. S. (2003). Fox's in development and disease. Trends Genet. 19, 339-344. doi: 10.1016/S0168-9525(03)00111-2
35. Li, T., Kung, H. J., Mack, P. C., and Gandara, D. R. (2013). Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J. Clin. Oncol. 31, 1039-1049. doi: 10.1200/JCO.2012.45.3753
36. Mologni, L. (2011). Development of RET kinase inhibitors for targeted cancer therapy. Curr. Med. Chem. 18, 162-175. doi: 10.2174/092986711794088308
37. Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K., and Varmus, H. (1984). Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307, 131-136. doi: 10.1038/307131a0
38. Ordovás, J. M., and Smith, C. E. (2010). Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 7, 510-519. doi: 10.1038/nrcardio.2010.104
39. Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., and Hartnett, M. E. (2008). Vascular endothelial growth factor in eye disease. Prog. Retin. Eye Res. 27, 331-371. doi: 10.1016/j.preteyeres.2008.05.001
40. Philips, G. M., Chan, I. S., Swiderska, M., Schroder, V. T., Guy, C., Karaca, G. F., et al. (2011). Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer. PLoS ONE 6:e23943. doi: 10.1371/journal.pone.0023943
41. Sagara, N., Toda, G., Hirai, M., Terada, M., and Katoh, M. (1998). Molecular cloning, differential expression, and chromosomal localization of human Frizzled-1, Frizzled-2, and Frizzled-7. Biochem. Biophys. Res. Commun. 252, 117-122. doi: 10.1006/bbrc.1998.9607
42. Santo, E. E., Ebus, M. E., Koster, J., Schulte, J. H., Lakeman, A., van Sluis, P., et al. (2012). Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma. Oncogene 31, 1571-1581. doi: 10.1038/onc.2011.344
43. Sexton, P. M., and Wootten, D. (2013). Structural biology: meet the B family. Nature 499, 417-418. doi: 10.1038/nature12413
44. Sinclair, D. A., Milne, T. A., Hodgson, J. W., Shellard, J., Salinas, C. A., Kyba, M., et al. (1998). The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes. Development 125, 1207-1216
45. Tammela, T., Enholm, B., Alitalo, K., and Paavonen, K. (2005). The biology of vascular endothelial growth factors. Cardiovasc. Res. 65, 550-563. doi: 10.1016/j.cardiores.2004.12.002
46. Turchinovich, A., Weiz, L., and Burwinkel, B. (2012). Extracellular miRNAs: the mystery of their origin and function. Trends Biochem. Sci. 37, 460-465. doi: 10.1016/j.tibs.2012.08.003
47. Wittmann, J., and Jäck, H. M. (2010). Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta. 1806, 200-207